Applied DNA Stock Jumps On New COVID-19 Testing Contract

Applied DNA Sciences Inc's (NASDAQ:APDN) subsidiary Applied DNA Clinical Labs has been awarded a testing contract by Suffolk County Community College.
Also Read: Applied DNA Receives COVID-19 testing contract by the City University of New York
Testing is scheduled to begin in the second half of September 2021. The initial contract term is one year and includes two one-year options for renewal.
The contract contains no minimum testing requirement; it stipulates a fixed monthly fee for sample collection site services and a separate fixed fee per individual COVID-19 test.
Under the Contract, Applied DNA will deploy safeCircle, a pooled COVID-19 testing program.
Price Action: APDN stock is up 3.07% at $6.05 during the premarket session on the last check Thursday.

To add Benzinga News as your preferred source on Google, click here.